Rachael Brake

Rachael Brake is a seasoned professional in the field of oncology and biochemistry, currently serving as Chief Scientific Officer at Zephyr AI and previously at Corbus Pharmaceuticals. With extensive experience in the pharmaceutical industry, Rachael's roles have included Head of US Medical Affairs Oncology and Global Program Lead at Takeda Oncology, along with various positions at Amgen such as Principal Scientist and Senior Scientist. Rachael's academic credentials include a PhD in Biochemistry and Molecular Biology from The University of Western Australia and ongoing studies for a BSc with Honors in Molecular Biology and Biochemistry at The Australian National University.